| Apolipoprotein C-III: understanding an emerging cardiovascular risk factor EMM Ooi, PHR Barrett, DC Chan, GF Watts Clinical science 114 (10), 611-624, 2008 | 425 | 2008 |
| Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men DC Chan, GF Watts, PHR Barrett, V Burke Qjm 96 (6), 441-447, 2003 | 412 | 2003 |
| Randomized controlled trial of the effect of n–3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity DC Chan, GF Watts, TA Mori, PHR Barrett, TG Redgrave, LJ Beilin The American journal of clinical nutrition 77 (2), 300-307, 2003 | 370 | 2003 |
| Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome GF Watts, PHR Barrett, J Ji, AP Serone, DC Chan, KD Croft, F Loehrer, ... Diabetes 52 (3), 803-811, 2003 | 246 | 2003 |
| Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidaemia MS Farvid, TWK Ng, DC Chan, PHR Barrett, GF Watts Diabetes, obesity and metabolism 7 (4), 406-413, 2005 | 234 | 2005 |
| Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity DC Chan, GF Watts, PHR Barrett, LJ Beilin, TA Mori Clinical Chemistry 48 (6), 877-883, 2002 | 228 | 2002 |
| Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia DC Chan, GF Watts, PHR Barrett, LJ Beilin, TG Redgrave, TA Mori Diabetes 51 (8), 2377-2386, 2002 | 205 | 2002 |
| Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet DC Chan, GF Watts, SK Gan, EMM Ooi, PHR Barrett Diabetes Care 33 (5), 1134-1139, 2010 | 182 | 2010 |
| Dyslipidemia in visceral obesity: mechanisms, implications, and therapy DC Chan, HPR Barrett, GF Watts American Journal of Cardiovascular Drugs 4, 227-246, 2004 | 178 | 2004 |
| Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration DC Chan, GF Watts, TG Redgrave, TA Mori, PHR Barrett Metabolism-Clinical and Experimental 51 (8), 1041-1046, 2002 | 172 | 2002 |
| Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism DC Chan, GF Watts, TWK Ng, Y Uchida, N Sakai, S Yamashita, ... Clinical chemistry 51 (3), 578-585, 2005 | 164 | 2005 |
| Apolipoproteins as markers and managers of coronary risk DC Chan, GF Watts Journal of the Association of Physicians 99 (5), 277-287, 2006 | 149 | 2006 |
| Controlled study of the effect of proprotein convertase subtilisin-kexin type 9 inhibition with evolocumab on lipoprotein (a) particle kinetics GF Watts, DC Chan, R Somaratne, SM Wasserman, R Scott, ... European heart journal 39 (27), 2577-2585, 2018 | 145 | 2018 |
| Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity DC Chan, GF Watts, PH Barrett, JCL Mamo, TG Redgrave Clinical Chemistry 48 (2), 278-283, 2002 | 145 | 2002 |
| Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics? TWK Ng, GF Watts, MS Farvid, DC Chan, PHR Barrett Diabetes 54 (3), 795-802, 2005 | 144 | 2005 |
| Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels TWK Ng, GF Watts, PHR Barrett, KA Rye, DC Chan Diabetes care 30 (11), 2945-2950, 2007 | 132 | 2007 |
| Demystifying the management of hypertriglyceridaemia GF Watts, EMM Ooi, DC Chan Nature reviews Cardiology 10 (11), 648-661, 2013 | 127 | 2013 |
| Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity DC Chan, GF Watts, TA Mori, PHR Barrett, LJ Beilin, TG Redgrave European journal of clinical investigation 32 (6), 429-436, 2002 | 125 | 2002 |
| Factorial study of the effect of n–3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins AI and A-II in men with abdominal obesity DC Chan, GF Watts, MN Nguyen, PHR Barrett The American journal of clinical nutrition 84 (1), 37-43, 2006 | 124 | 2006 |
| Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies DC Chan, GF Watts Expert opinion on pharmacotherapy 12 (1), 13-30, 2011 | 111 | 2011 |
